Literature DB >> 33623620

COVID-19 infection during autoimmune disease: study of 2 cases in Republic of Guinea.

Kaba Condé1,2, Hugues Ghislain Atakla1, Mahaman Salissou Garba3, Idé Garba3.   

Abstract

INTRODUCTION: Coronavirus is a virus that can target the respiratory, musculoskeletal systems with a cascade of inflammatory processes. The objective of this work is to establish the link between autoimmune diseases and a COVID-19 infection in Guinea.
METHODS: Retrospective patient data were obtained from medical records. Informed consent was obtained under the direction of the national health security agency (ANSS).
RESULTS: We report the case of two patients aged 52 and 64 years respectively, known to have rheumatoid arthritis (RA) and systemic scleroderma (SDS) admitted with clinical signs suggesting underlying infection with COVID-19. They were tested with RT-PCR, which was positive within hours.
CONCLUSION: In view of the rapid clinical worsening of patients with COVID-19 infection and autoimmune diseases, increased surveillance should be undertaken with abstinence of any factors that might weaken the immunity of these patients. © Kaba Condé et al.

Entities:  

Keywords:  COVID-19; Guinea; rheumatoid arthritis; systemic scleroderma

Mesh:

Year:  2020        PMID: 33623620      PMCID: PMC7875779          DOI: 10.11604/pamj.supp.2020.35.2.24616

Source DB:  PubMed          Journal:  Pan Afr Med J


  11 in total

1.  Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.

Authors:  Jianjun Gao; Zhenxue Tian; Xu Yang
Journal:  Biosci Trends       Date:  2020-02-19       Impact factor: 2.400

2.  Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study.

Authors:  Michele F Doran; Cynthia S Crowson; Gregory R Pond; W Michael O'Fallon; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2002-09

Review 3.  The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment.

Authors:  Joachim Listing; Kerstin Gerhold; Angela Zink
Journal:  Rheumatology (Oxford)       Date:  2012-11-28       Impact factor: 7.580

4.  Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.

Authors:  Martin J Vincent; Eric Bergeron; Suzanne Benjannet; Bobbie R Erickson; Pierre E Rollin; Thomas G Ksiazek; Nabil G Seidah; Stuart T Nichol
Journal:  Virol J       Date:  2005-08-22       Impact factor: 4.099

5.  Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity.

Authors:  Y S Lin; C F Lin; Y T Fang; Y M Kuo; P C Liao; T M Yeh; K Y Hwa; C C K Shieh; J H Yen; H J Wang; I J Su; H Y Lei
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

6.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Authors:  Xiaobo Yang; Yuan Yu; Jiqian Xu; Huaqing Shu; Jia'an Xia; Hong Liu; Yongran Wu; Lu Zhang; Zhui Yu; Minghao Fang; Ting Yu; Yaxin Wang; Shangwen Pan; Xiaojing Zou; Shiying Yuan; You Shang
Journal:  Lancet Respir Med       Date:  2020-02-24       Impact factor: 30.700

Review 7.  COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments.

Authors:  Dieu-Donné Ouédraogo; Wendlassida Joelle Stéphanie Tiendrébéogo; Fulgence Kaboré; Honoré Ntsiba
Journal:  Clin Rheumatol       Date:  2020-05-29       Impact factor: 2.980

Review 8.  COVID-19 infection and rheumatoid arthritis: Faraway, so close!

Authors:  Ennio Giulio Favalli; Francesca Ingegnoli; Orazio De Lucia; Gilberto Cincinelli; Rolando Cimaz; Roberto Caporali
Journal:  Autoimmun Rev       Date:  2020-03-20       Impact factor: 9.754

9.  A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19.

Authors:  Andrea Cortegiani; Giulia Ingoglia; Mariachiara Ippolito; Antonino Giarratano; Sharon Einav
Journal:  J Crit Care       Date:  2020-03-10       Impact factor: 3.425

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.